Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Matteo Morra"'
Autor:
Pasquale De Nardo, Maela Tebon, Alessia Savoldi, Nicola Soriolo, Elisa Danese, Denise Peserico, Matteo Morra, Elisa Gentilotti, Gulser Caliskan, Pierpaolo Marchetti, Riccardo Cecchetto, Annarita Mazzariol, Giuseppe Verlato, Davide Gibellini, Evelina Tacconelli
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 4, Pp 1073-1082 (2023)
Abstract Introduction Detection strategies in vulnerable populations such as people experiencing homelessness (PEH) need to be explored to promptly recognize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreaks. This study investiga
Externí odkaz:
https://doaj.org/article/cc5110a0e13d47bbb4266e323f1483da
Autor:
Elda Righi, Ilaria Dalla Vecchia, Nina Auerbach, Matteo Morra, Anna Górska, Concetta Sciammarella, Lorenza Lambertenghi, Elisa Gentilotti, Massimo Mirandola, Evelina Tacconelli, Assunta Sartor
Publikováno v:
Microorganisms, Vol 12, Iss 1, p 131 (2024)
COVID-19 has been associated with having a negative impact on patients’ gut microbiome during both active disease and in the post-acute phase. In acute COVID-19, rapid alteration of the gut microbiome composition was observed, showing on one side a
Externí odkaz:
https://doaj.org/article/81139ac724e84a9b997d6f1b7a075810
Autor:
Akshita Gupta, Angelina Konnova, Mathias Smet, Matilda Berkell, Alessia Savoldi, Matteo Morra, Vincent Van averbeke, Fien H.R. De Winter, Denise Peserico, Elisa Danese, An Hotterbeekx, Elda Righi, mAb ORCHESTRA working group, Pasquale De Nardo, Evelina Tacconelli, Surbhi Malhotra-Kumar, Samir Kumar-Singh
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 6 (2023)
Background The role of host immunity in emergence of evasive SARS-CoV-2 Spike mutations under therapeutic monoclonal antibody (mAb) pressure remains to be explored.Methods In a prospective, observational, monocentric ORCHESTRA cohort study, conducted
Externí odkaz:
https://doaj.org/article/d56a05fdc7834e8aaca163e81efb040b
Autor:
Fulvia Mazzaferri, Massimo Mirandola, Alessia Savoldi, Pasquale De Nardo, Matteo Morra, Maela Tebon, Maddalena Armellini, Giulia De Luca, Lucrezia Calandrino, Lolita Sasset, Denise D'Elia, Emanuela Sozio, Elisa Danese, Davide Gibellini, Isabella Monne, Giovanna Scroccaro, Nicola Magrini, Annamaria Cattelan, Carlo Tascini, MANTICO Working Group, Evelina Tacconelli
Publikováno v:
eLife, Vol 11 (2022)
Background: Recent in-vitro data have shown that the activity of monoclonal antibodies (mAbs) targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) varies according to the variant of concern (VOC). No studies have compared the clinic
Externí odkaz:
https://doaj.org/article/2a21889f4499475c95b4662dcd4844a9
Autor:
Alessia Savoldi, Matteo Morra, Alessandro Castelli, Massimo Mirandola, Matilda Berkell, Mathias Smet, Angelina Konnova, Elisa Rossi, Salvatore Cataudella, Pasquale De Nardo, Elisa Gentilotti, Akshita Gupta, Daniele Fasan, Enrico Gibbin, Filippo Cioli Puviani, Jan Hasenauer, Roy Gusinow, Adriana Tami, Samir Kumar-Singh, Surbhi Malhotra-Kumar, mAb ORCHESTRA Working Group, Evelina Tacconelli
Publikováno v:
Biomedicines, Vol 10, Iss 9, p 2063 (2022)
The clinical impact of anti-spike monoclonal antibodies (mAb) in Coronavirus Disease 2019 (COVID-19) breakthrough infections is unclear. We present the results of an observational prospective cohort study assessing and comparing COVID-19 progression
Externí odkaz:
https://doaj.org/article/ab6fcac758a4487c8de36256b61565fa
BackgroundRecent in-vitro data have shown that the activity of monoclonal antibodies (mAbs) targeting SARS-CoV-2 varies according to the Variant of Concern (VOC). No studies have compared the clinical efficacy of different mAbs against Omicron VOC.Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1aa24005f9ef6319cb3c58849396989a
https://doi.org/10.1101/2022.05.06.22274613
https://doi.org/10.1101/2022.05.06.22274613
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases